menu search

Gilead (gild) announces positive data on hepcludex for hdv

Gilead (GILD) Hepcludex meets the primary endpoint in a phase iiI study for the treatment of chronic he...

June 24, 2022, 2:00 pm

Biogen stops clinical trial tracking aduhelm

Biogen Inc. BiiB, +2.12% said in a statement that it stopped a post-marketing clinical trial testing it...

June 24, 2022, 8:12 am

Ortho regenerative technologies highlights milestones achieved in 1q ended april 30, 2022

Ortho Regenerative Technologies Inc (CSE:ORTH) has reported its financial results and highlights for the first quarter ended April 30, 2022. Among the...

June 24, 2022, 7:58 am

G-iii apparel group: why i'm optimistic on a rebound

G-iiI Apparel Group seems undervalued at the current price. It is uncertain whether recent COVID lockdo...

June 23, 2022, 5:53 pm

Here's why investors should retain hawaiian holdings (ha) now

Improvement in air-travel demand bodes well for Hawaiian Holdings (HA)....

June 23, 2022, 2:40 pm

Two-minute drill: lrcx, lii & vz

Burns McKinney, NFJ Investment Group, joins 'Closing Bell: Overtime to discuss volatility and the Fed, and what could spur the Fed to step back or be ...

June 22, 2022, 5:24 pm

Crispr therapeutics ag (crsp) management presents at innovation day conference (transcript)

CRISPR Therapeutics AG (NASDAQ:CRSP ) Innovation Day Conference Call June 21, 2022 2:00 PM ET Company Participants Samarth Kulkarni - Chief Executive ...

June 22, 2022, 11:40 am

Pfizer (pfe) to buy 8.1% stake in lyme disease vaccine partner

Pfizer (PFE) is set to acquire 8.1% stake in Valneva's stock. Valneva will use the cash from this investment to support its phase ...

June 21, 2022, 11:56 am

Insteel industries announces third quarter 2022 conference call

MOUNT AIRY, N.C.--(BUSINESS WIRE)--Insteel Industries Inc. (NYSE: iiIN) today announced that its third ...

June 21, 2022, 10:00 am

Astrazeneca hails phase iii success of drug for rare disease amyloid polyneuropathy

AstraZeneca PLC (LSE:AZN) will file a new drug application later this year after a successful phase iiI...

June 21, 2022, 3:34 am

Unicredit: no gift for russia

UniCredit won't completely write-off its Russian division. Russia Q1 performances were solid thanks to trading activities and N...

June 20, 2022, 10:09 am

Innovative industrial properties: short-term price loss, long-term potential

Despite a huge price loss in the past 7 months, iiPR has generated extraordinarily high returns for its...

June 19, 2022, 1:07 pm

Innovative industrial properties: far too cheap by any valuation metric

iiPR has been pummeled this year. However, its model has proven resilient and it should be fairly insul...

June 19, 2022, 2:36 am

14 june high-yield and high-rising dividend dogs ready to buy

June 2022, The AAii Journal listed two sets of stocks sorted as: High-Yielding Dividend Payers, and Big...

June 16, 2022, 11:09 pm

Syntax launches stratified total market ii etf

Syntax Advisors LLC has launched the Syntax Stratified Total Market ii ETF (NYSE Arca: SY...

June 16, 2022, 2:31 pm

Pfizer (pfe) covid pill ineffective in standard risk patients

Pfizer (PFE) stops enrolling patients in a phase ii/iiI ...

June 15, 2022, 4:58 pm

G-iii apparel (giii) buoyant on digital & brand strength

G-iiI Apparel's (GiiI) brand strength and robust busines...

June 15, 2022, 4:58 pm

Karyopharm therapeutics' shares slide after biogen terminates 2018 asset purchase agreement

Biogen Inc. (NASDAQ: BiiB) has informed Karyopharm Therapeutics Inc (NASDAQ: KPTI) that it has opted...

June 15, 2022, 4:58 pm

Two retailers the analysts are buying

The retail sector has had a hard time of it the last few months but now there are some opportunities emerging. Companies like Skechers (NYSE: SKX) and...

June 15, 2022, 10:03 am

Hyliion to participate in upcoming investor conferences

AUSTIN, Texas--(BUSINESS WIRE)--Hyliion Holdings Corp. (NYSE: HYLN) (“Hyl...

June 15, 2022, 9:22 am


Search within

Pages Search Results: